...
首页> 外文期刊>American Journal of Translational Research >MicroRNA-205 inhibits the apoptosis of renal tubular epithelial cells via the PTEN/Akt pathway in renal ischemia-reperfusion injury
【24h】

MicroRNA-205 inhibits the apoptosis of renal tubular epithelial cells via the PTEN/Akt pathway in renal ischemia-reperfusion injury

机译:MicroRNA-205通过PTEN / AKT途径抑制肾小管上皮细胞的凋亡肾缺血再灌注损伤

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Renal ischemia-reperfusion injury (IRI) is the main cause of acute kidney injury (AKI). Many studies on renal IRI have been performed recently, but effective treatments are still lacking. Evidence exists that small endogenous noncoding RNAs are involved in the ischemia-reperfusion process. This article aims to investigate whether microRNA-205 (miR-205) is involved in this process and to determine its role in the hypoxia-induced injury of renal tubular epithelial cells (TECs). We found that miR-205 was significantly downregulated in rats with renal IRI and in HK-2 cells with hypoxia-reoxygenation injury (HRI) in vitro. In vitro, overexpression of intracellular miR-205 by transfection of a miR-205 mimic significantly reduced apoptosis, and this antiapoptotic effect was antagonized by a miR-205 inhibitor. Moreover, we confirmed that PTEN is a target of miR-205. miR-205 exerted its protective effect by inhibiting HK-2 cell apoptosis and promoting HK-2 cell proliferation by inhibiting the expression of PTEN during HRI, and this protective effect was blocked by silencing PTEN. Therefore, we confirmed that miR-205 may target the PTEN/Akt signaling pathway to alleviate hypoxia-induced renal cell damage. miR-205 may be a new potential target for the treatment of renal IRI.
机译:肾缺血再灌注损伤(IRI)是急性肾损伤(AKI)的主要原因。最近对肾IRI进行了许多研究,但仍然缺乏有效的治疗。存在证据表明,小内源性非分量RNA参与缺血再灌注过程。本文旨在调查MicroRNA-205(MIR-205)是否参与此过程,并确定其在缺氧诱导的肾小管上皮细胞(TECS)损伤中的作用。我们发现MiR-205在肾IRI的大鼠和HK-2细胞中显着下调,体外缺氧雷诺损伤(HRI)。体外,通过转染miR-205的细胞内miR-205的过表达明显降低的细胞凋亡,并且该抗凋亡效应由miR-205抑制剂拮抗。此外,我们证实PTEN是MIR-205的目标。 MiR-205通过抑制HK-2细胞凋亡并通过抑制HRI的表达来促进HK-2细胞增殖来施加其保护效果,并且通过沉默PTEN阻断这种保护作用。因此,我们确认MIR-205可以靶向PTEN / AKT信号通路以减轻缺氧诱导的肾细胞损伤。 MIR-205可能是治疗肾IRI的新潜在目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号